Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
3. Bharti R. Wadhwani KK, Tikku AP, Chandra A. Dental amalgam: an update.J Conserv Dent. 2010;13(4):204-208.
4. Letzel H, van 't Hof MA, Marshall GW, Marshall SJ. The influence of the amalgam alloy on the survival of amalgam restorations: a secondary analysis of multiple controlled clinical trials.J Dent Res. 1997;76(11):1787-1798.
5. Ritter AV, Boushell LW, Walter R.Sturdevant's Art and Science of Operative Dentistry. 7th ed. St. Louis, MO: Elsevier; 2019.
6. California Dental Association. Dental Amalgam: Public Health and the Environment. Available athttps://www.cda.org/Portals/0/pdfs/policy_statements/issue_amalgam.pdf. Last accessed January 10, 2023.
7. Colgate. Dental Amalgam: Is It Safe? Available at https://www.colgate.com/en-us/oral-health/fillings/dental-amalgam-a-health-risk#. Last accessed January 10, 2023.
8. Rathore M, Singh A, Pant VA. The dental amalgam toxicity fear: a myth or actuality.Toxicol Int. 2012;19(2):81-88.
9. Designs for Dental Health. Mercury Amalgam Fillings Banned. Available at http://designsfordentalhealth.com/nadler-blog/mercury-amalgam-fillings-banned. Last accessed January 10, 2023.
10. U.S. Food and Drug Administration. White Paper: FDA Update/Review of Potential Adverse Health Risks Associated with Exposure to Mercury in Dental Amalgam. Available athttps://www.fda.gov/medical-devices/dental-amalgam/white-paper-fda-updatereview-potential-adverse-health-risks-associated-exposure-mercury-dental. Last accessed January 10, 2023.
11. U.S. Department of Health and Human Services Public Health Service.Dental Amalgam: A Scientific Review and Recommended Public Health Service Strategy for Research, Education and Regulation. Rockville, MD: Public Health Service; 1993.
12. Life Sciences Research Organization. Review and Analysis of the Literature on the Potential Health Effects of Dental Amalgams. Available athttp://www.lsro.org/amalgam/frames_amalgam_home.html. Last accessed January 10, 2023.
13. 13. Federal Register. Dental Devices: Classification of Dental Amalgam, Reclassification of Dental Mercury, Designation of Special Controls for Dental Amalgam, Mercury, and Amalgam Alloy; Technical Amendment: A Rule by the Food and Drug Administration. Available at https://www.federalregister.gov/documents/2010/06/11/2010-14083/dental-devices-classification-of-dental-amalgam-reclassification-of-dental-mercury-designation-of. Last accessed January 10, 2023.
14. U.S. Food and Drug Administration. FDA Issues Recommendations for Certain High-Risk Groups Regarding Mercury-Containing Dental Amalgam. Available athttps://www.fda.gov/news-events/press-announcements/fda-issues-recommendations-certain-high-risk-groups-regarding-mercury-containing-dental-amalgam. Last accessed January 10, 2023.
15. European Commission Scientific Committee on Emerging and Newly Identified Health Risks. The Safety of Dental Amalgam and Alternative Dental Restoration Materials for Patients and Users. Available athttps://ec.europa.eu/health/archive/ph_risk/committees/04_scenihr/docs/scenihr_o_016.pdf. Last accessed January 10, 2023.
16. U.S. Food and Drug Administration. Center for Devices and Radiological Health. Epidemiological Evidence on the Adverse Health Effects Reported in Relation to Mercury from Dental Amalgam: Systematic Literature Review (2010-Present). Available at https://www.fda.gov/media/131151/download. Last accessed January 10, 2023.
17. Murthy VH. Community water fluoridation: one of CDC's "10 Great Public Health Achievements of the 20th Century."Pub Health Rep. 2015;130(4):296-298.
18. Centers for Disease Control and Prevention. Community Water Fluoridation: 2018 Fluoridation Statistics. Available at https:// www.cdc.gov/fluoridation/statistics/2018stats.htm. Last accessed January 10, 2023.
19. American Academy of Pediatric Dentistry. Fluoride Therapy. Available athttps://www.aapd.org/globalassets/media/policies_guidelines/bp_fluoridetherapy.pdf. Last accessed January 10, 2023.
20. U.S. Department of Health and Human Services Federal Panel on Community Water Fluoridation. U.S. Public Health Service recommendation for fluoride concentration in drinking water for the prevention of dental caries.Public Health Rep. 2015;130(4):318-331.
21. 21. Centers for Disease Control and Prevention. Community Water Fluoridation FAQs. Available athttps://www.cdc.gov/fluoridation/faqs/index.htm. Last accessed January 10, 2023.
22. National Research Council, Division on Earth and Life Studies, Board on Environmental Studies and Toxicology, Committee on Fluoride in Drinking Water.Fluoride in Drinking Water: A Scientific Review of EPA's Standards. Washington, DC: National Academies Press; 2007.
23. New Hampshire Department of Environmental Services. Environmental Fact Sheet: Fluoride in Drinking Water. Available at https://www.des.nh.gov/sites/g/files/ehbemt341/files/documents/2020-01/dwgb-3-5.pdf. Last accessed January 10, 2023.
24. World Health Organization. Drinking Water. Available at https://www.who.int/news-room/fact-sheets/detail/drinking-water. Last accessed January 10, 2023.
25. Beltrán-Aguilar ED, Barker L, Dye BA. NCHS data brief No. 53: prevalence and severity of dental fluorosis in the United States, 1999–2004.NCHS Data Brief. 2010;(53):1-8.
27. Centers for Disease Control and Prevention. Statement on the Evidence Supporting the Safety and Effectiveness of Community Water Fluoridation. Available athttps://www.cdc.gov/fluoridation/guidelines/cdc-statement-on-community-water-fluoridation.html. Last accessed January 10, 2023.
28. 28. Green R, Lanphear B, Hornung R, et al. Association between maternal fluoride exposure during pregnancy and IQ scores in offspring in Canada.JAMA Pediatr. 2019;173(10):940-948.
29. Bashash M, Thomas D, Hu H, et al. Prenatal fluoride exposure and cognitive outcomes in children at 4 and 6–12 years of age in Mexico.Environ Health Perspect. 2017;125(9):097017.
30. Das K, Mondal NK. Dental fluorosis and urinary fluoride concentration as a reflection of fluoride exposure and its impact on IQ level and BMI of children of Laxmisagar, Simlapal Block of Bankura District, W.B., India.Environ Monit Assess. 2016;188(4):218.
31. Till C, Green R. Controversy: the evolving science of fluoride: when new evidence doesn't conform with existing beliefs.Pediatr Res. 2021;90(5):1093-1095.
32. Grandjean P. Developmental fluoride neurotoxicity: an updated review.Environ Health. 2019;18(1):110.
33. 33. Till C, Green R, Flora D, et al. Fluoride exposure from infant formula and child IQ in a Canadian birth cohort.Environ Int. 2020;134:105315.
34. Jenco M. AAP Continues to Recommend Fluoride Following New Study on Maternal Intake and Child IQ. Available at https://publications.aap.org/aapnews/news/6598?autologincheck=redirected. Last accessed January 10, 2023.
35. American Dental Association. News Releases: ADA Statement on Study in JAMA Pediatrics. Available at https://health.mo.gov/ living/families/oralhealth/pdf/ada-study-jama-pediatrics.pdf. Last accessed January 10, 2023.
36. Public Broadcasting Service. Fleming Discovers Penicillin 1928–1945. Available athttp://www.pbs.org/wgbh/aso/databank/entries/dm28pe.html. Last accessed January 10, 2023.
37. Dar-Odeh NS, Abu-Hammad OA, Al-Omiri MK, Khraisat AS, Shehabi AA. Antibiotic prescribing practices by dentists: a review.Ther Clin Risk Manag. 2010;6:301-306.
38. Hellden LB, Listgarten MA, Lindhe J. The effect of tetracycline and/or scaling on human periodontal disease.J Clin Periodontol. 1979;6(4):222-230.
39. Slots J, Mashimo P, Levine MJ, Genco RJ. Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy.J Periodontol. 1979;50(10):495-509.
40. Bollen CM, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy: a review of the literature.J Periodontol. 1996;67(11):1143-1158.
41. Silva-Senem MX, Heller D, Varela VM, Torres MCB, Feres-Filho EJ, Colombo APV. Clinical and microbiological effects of systemic antimicrobials combined to an anti-infective mechanical debridement for the management of aggressive periodontitis: a 12-month randomized controlled trial.J Clin Periodontol. 2013;40(3):242-251.
42. Hagenfeld D, Koch R, Junemann S, et al. Do we treat our patients or rather periodontal microbes with adjunctive antibiotics in periodontal therapy? A 16S rDNA microbial community analysis.PLoS One. 2018;13(4):e0195534.
43. European Federation of Periodontology. Debate: Is it Time for a Rethink on the Use of Antibiotics to Treat Periodontitis? Available at https://www.efp.org/news-events/news/debate-is-it-time-for-a-rethink-on-the-use-of-antibiotics-to-treat-periodontitis-29978/. Last accessed January 10, 2023.
44. Walker C. The supplemental use of antibiotics in periodontal therapy.Compend Contin Educ Dent. 1999;20(4):4-12.
45. 45. Kapoor A, Malhotra R, Grover V, Grover D. Systemic antibiotic therapy in periodontics.Dent Res J (Isfahan). 2012;9(5):505-515.
46. Rajendra A, Spivakovsky S. Antibiotics in aggressive periodontitis: is there a clinical benefit?Evid Based Dent. 2016;17(4):100.
47. Barca E, Cifcibasi E, Cintan S. Adjunctive use of antibiotics in periodontal therapy.J Istanb Univ Fac Dent. 2015;49(3):55-62.
48. Salako NO, Rotimi VO, Adib SM, Al-Mutawa S. Pattern of antibiotic prescription in the management of oral diseases among dentists in Kuwait.J Dent. 2004;32(7):503-509.
49. Oomens MA, Forouzanfar T. Antibiotic prophylaxis in third molar surgery: a review.Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114(6):e5-e12.
50. 50. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity.BMC Pregnancy Childbirth. 2009;9:26.
51. Little JW, Miller C, Rhodus NL.Little and Falace's Dental Management of the Medically Compromised Patient. 9th ed. St. Louis, MO: Elsevier; 2018.
52. Merck Manual. Drugs in Pregnancy. Available athttps://www.merckmanuals.com/professional/gynecology-and-obstetrics/drugs-in-pregnancy/drugs-in-pregnancy. Last accessed January 10, 2023.
53. Federal Register. Content and Format of Labeling for Human Prescription Drug and Biological Products: Requirements for Pregnancy and Lactation Labeling. Available athttps://www.federalregister.gov/articles/2014/12/04/2014-28241/content-and-format-of-labeling-for-human-prescription-drug-and-biological-products-requirements-for. Last accessed January 10, 2023.
54. Gaffney A. FDA Scraps Pregnancy Labeling Classification System in Favor of New Standard. Available athttps://www.raps.org/regulatory-focus%e2%84%a2/news-articles/2014/12/fda-scraps-pregnancy-labeling-classification-system-in-favor-of-new-standard. Last accessed January 10, 2023.
55. U.S. Food and Drug Administration. Pregnancy and Lactation Labeling Final Rule. Available athttps://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule. Last accessed January 10, 2023.
56. U.S. Food and Drug Administration. FDA Issues Final Rule on Changes to Pregnancy and Lactation Labeling Information for Prescription Drug and Biological Products. Available athttps://wayback.archive-it.org/7993/20170111093956/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317.htm. Last accessed January 10, 2023.
57. Kurien S, Kattimani VS, Sriram RR, et al. Management of pregnant patient in dentistry.J Int Oral Health. 2013;5(1):88-97.
58. American Dental Association Council on Access, Prevention, and Interprofessional Relations. Women's oral health issues. In:ADA Oral Health Care Series. Chicago, IL: American Dental Association; 1995: 9.
59. Patton LL, Glick M.The ADA Practical Guide to Patients with Medical Conditions. 2nd ed. Hoboken, NJ: Wiley Blackwell; 2016.
60. Kornman KS, Loesche WJ. The subgingival microbial flora during pregnancy.J Periodont Res. 1980;15(2):111-122.
61. Carrillo-de-Albornoz A, Figuero E, Herrera D, Bascones-Martinez A. Gingival changes during pregnancy: II. Influence of hormonal variations on the subgingival biofilm.J Clin Periodontol. 2010;37(3):230-240.
62. Markou E, Eleana B, Lazaros T, Antonios K. The influence of sex steroid hormones on gingiva of women.Open Dent J. 2009;3:114-119.
63. Lindhe J, Branemark PI. Changes in vascular permeability after local application of sex hormones.J Periodontol Res. 1967;2(4):259-265.
64. Mariotti A. Sex steroid hormones and cell dynamics in the periodontium.Crit Rev Oral Biol Med. 1994;5(1):27-53.
65. Soory M. Targets for steroid hormone mediated actions of periodontal pathogens, cytokines and therapeutic agents: some implications on tissue turnover in the periodontium.Curr Drug Targets. 2000;1(4):309-325.
66. Barnett ML. The oral-systemic disease connection: an update for the practicing dentist.J Am Dent Assoc. 2006;137:5S-6S.
67. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction.BMJ. 1989;298(6676):779-781.
68. Chang Y, Woo HG, Lee JS, Song TJ. Better oral hygiene is associated with lower risk of stroke.J Periodontol. 2021;92(1):87-94.
69. Carrizales-Sepúlveda EF, Ordaz-Farías A, Vera-Pineda R, Flores-Ramírez R. Periodontal disease systemic inflammation and the risk of cardiovascular disease.Heart Lung Circ. 2018;27(11):1327-1334.
70. Priyamvara A, Dey AK, Bandyopadhyay D, et al. Periodontal inflammation and the risk of cardiovascular disease.Curr Atheroscler Rep. 2020;22(7):28.
71. Sanz M, Del Castillo AM, Jepsen S, et al. Periodontitis and cardiovascular diseases: consensus report.J Clin Periodontol. 2020;47(3): 268-288.
72. Lam OL, Zhang W, Samaranayake LP, Li LS, McGrath C. A systematic review of the effectiveness of oral health promotion activities among patients with cardiovascular disease.Int J Cardiol. 2011;151(3):261-267.
73. Bui FQ, Almeida-da-Silva CLC, Huynh B, et al. Association between periodontal pathogens and systemic disease.Biomed J. 2019;42(1):27-35.
74. Joshipura K, Zevallos JC, Ritchie CS. Strength of evidence relating to periodontal disease and atherosclerotic disease.Compend Contin Educ Dent. 2009;30(7):430-439.
75. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques.J Periodontol. 2000;71(10):1554-1560.
76. Herzberg MC, Meyer MW. Effects of oral flora on platelets: possible consequences in cardiovascular disease.J Periodontol. 1996;67(10):1138-1142.
77. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease.Clin Microbiol Infect. 2007;13(4):3-10.
78. Issrani R, Reddy J, El-Metwally Dabah TH, et al. Exploring the mechanisms and association between oral microflora and systemic diseases.Diagnostics (Basel). 2022;12(11):2800.
79. Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology.J Clin Periodontol. 2018;45(2):138-149.
80. Fong IW. Infections and their role in atherosclerotic vascular disease.J Am Dent Assoc. 2002;133:7S-13S.
81. Meisel P, Kohlmann T, Wallaschofski H, Kroemer HK, Kocher T. Cholesterol, c-reactive protein, and periodontitis: HMG-CoA reductase inhibitors (statins) as effect modifiers.ISRN Dent. 2011;2011:125168.
82. Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks?Ann Intern Med. 1999;130(11):933-937.
83. D'Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers.J Dent Res. 2004;83(2):156-160.
84. Lalla E, Cheng B, Lal S, et al. Periodontal changes in children and adolescents with diabetes. Diabetes Care. 2006;29(2):295-299.
85. American Academy of Periodontology. Gum Disease and Other Diseases: Diabetes. Available at https://www.perio.org/for-patients/gum-disease-information/gum-disease-and-other-diseases/. Last accessed January 10, 2023.
86. Preshaw PM, Alba AL, Herrera D, et al. Periodontitis and diabetes: a two-way relationship.Diabetologia. 2012;55(1):21-31.
87. Shinkai RS, Hatch JP, Cornell JE, Yeh CK. Intraoral tactile sensitivity in adults with diabetes.Diabetes Care. 2004;27(4):869-873.
88. 88. Mealey BL, Oates TW. Diabetes mellitus and periodontal disease.J Periodontol. 2006;77(8):1289-303.
89. Southerland JH, Taylor GW, Offenbacher S. Diabetes and periodontal infection: making the connection.Clin Diabetes. 2005;23(4):171-178.
90. Westerfield J, Holcomb S, Jensen S (eds).Current Trends in Diabetes Management: A Guide for the Healthcare Professional. 7th ed. Nashville, TN: Healthways; 2005.
91. Lorber D. Macrovascular disease in diabetes. In: Mensing C (ed).The Art and Science of Diabetes Self-Management Education: Desk Reference. 3rd ed. Chicago, IL: American Association of Diabetes Educators; 2014.
92. Cummings KM. Programs and policies to discourage the use of tobacco products.Oncogene. 2002;21(48):7349-7364.
93. 93. U.S. Department of Health, Education, and Welfare. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. 1964. Available athttps://www.govinfo.gov/content/pkg/GPO-SMOKINGANDHEALTH/pdf/GPO-SMOKINGANDHEALTH.pdf. Last accessed January 10, 2023.
94. Centers for Disease Control and Prevention. Burden of Cigarette Use in the U.S. Available at https://www.cdc.gov/tobacco/campaign/tips/resources/data/cigarette-smoking-in-united-states.html. Last accessed January 10, 2023.
95. Centers for Disease Control and Prevention. Smoking and Tobacco Use: Fast Facts and Fact Sheets. Available athttps://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/. Last accessed January 10, 2023.
96. Centers for Disease Control and Prevention. Current cigarette smoking among adults—United States, 2016.MMWR. 2018;67(2):54-59.
97. Wang TW, Asman K, Gentzke AS, et al. Tobacco product use among adults—United States, 2017.MMWR. 2018;67(44):1225-1232.
98. Centers for Disease Control and Prevention. Smokeless Tobacco Use in the United States. Available athttps://www.cdc.gov/tobacco/data_statistics/fact_sheets/smokeless/use_us/index.htm. Last accessed January 10, 2023.
99. Lipari RN, Van Horn SL.Trends in Smokeless Tobacco Use and Initiation: 2002 to 2014. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017.
100. 100. Centers for Disease Control and Prevention. Smokeless Tobacco: Products and Marketing. Available athttps://www.cdc.gov/tobacco/data_statistics/fact_sheets/smokeless/products_marketing/index.htm. Last accessed January 10, 2023.
101. Maxwell JC. The Maxwell Report: The Smokeless Tobacco Industry in 2011. Richmond, VA: John Maxwell, Jr.; 2011
102. Centers for Disease Control and Prevention. Smokeless Tobacco Product Use in the United States. Available at https://www.cdc.gov/tobacco/data_statistics/fact_sheets/smokeless/use_us/. Last accessed January 10, 2023.
103. Benowitz NL. Neurobiology of nicotine addiction: implications for smoking cessation treatment.Am J Med. 2008;121(4 Suppl 1):S3-S10.
104. Johns Hopkins Medicine. Oral Cancer and Tobacco. Available at https://www.hopkinsmedicine.org/health/conditions-and-diseases/oral-cancer-and-tobacco#. Last accessed January 10, 2023.
105. Centers for Disease Control and Prevention. About Electronic Cigarettes (E-Cigarettes). Available at https://www.cdc.gov/tobacco/basic_information/e-cigarettes/about-e-cigarettes.html. Last accessed January 10, 2023.
106. National Institute on Drug Abuse. Vaping Devices (Electronic Cigarettes) DrugFacts. Available at https://nida.nih.gov/publications/drugfacts/vaping-devices-electronic-cigarettes. Last accessed January 10, 2023.
107. Sun R, Mendez D, Warner KE. Trends in nicotine product use among US adolescents, 1999-2020.JAMA Netw Open. 2021;4(8):e2118788.
108. U.S. Food and Drug Administration. FDA Takes New Steps to Address Epidemic of Youth E-Cigarette Use, Including a Historic Action Against More Than 1,300 Retailers and 5 Major Manufacturers for Their Roles Perpetuating Youth Access. Available athttps://www.fda.gov/news-events/press-announcements/fda-takes-new-steps-address-epidemic-youth-e-cigarette-use-including-historic-action-against-more. Last accessed January 10, 2023.
109. U.S. Food and Drug Administration. FDA Finalized Enforcement Policy on Unauthorized Flavored Cartridge-Based E-Cigarettes that Appeal to Children, Including Fruit and Mint. Available athttps://www.fda.gov/news-events/press-announcements/fda-finalizes-enforcement-policy-unauthorized-flavored-cartridge-based-e-cigarettes-appeal-children. Last accessed January 10, 2023.
110. Altschuler C. Dangerous liaisons: the hazardous attraction of e-cigarettes, hookahs, and smokeless tobacco products.AGD Impact. 2015;43(5):18-23.
111. Knishkowy B, Amitai Y. Water-pipe (narghile) smoking: an emerging health risk behavior.Pediatrics. 2005;116(1):e113-e119.
112. Kiter G, Uçan ES, Ceylan E, Kilinç O. Water-pipe smoking and pulmonary functions.Respir Med. 2000;94(9):891-894.
113. WHO Study Group on Tobacco Product Regulation. Advisory Note: Waterpipe Tobacco Smoking: Health Effects, Research Needs and Recommended Actions by Regulators. Available at https://apps.who.int/iris/bitstream/handle/10665/43378/9241593857_eng.pdf?sequence=1. Last accessed January 10, 2023.
114. 114. Ward KD, Eissenberg T, Gray JN, Srinivas V, Wilson N, Maziak W. Characteristics of U.S. waterpipe users: a preliminary report.Nicotine Tob Res. 2007;9(12):1339-1346.
115. U.S. Food and Drug Administration. Hookah Tobacco (Shisha or Waterpipe Tobacco). Available at https://www.fda.gov/tobacco-products/products-ingredients-components/hookah-tobacco-shisha-or-waterpipe-tobacco#references. Last accessed January 10, 2023.
116. Sepetdjian E, Shihadeh A, Saliba NA. Measurement of 16 polycyclic aromatic hydrocarbons in narghile waterpipe tobacco smoke.Food Chem Toxicol. 2008;46(5):1582-1590.
117. Saleh R, Shihadeh A. Elevated toxicant yields with narghile waterpipes smoked using a plastic hose.Food Chem Toxicol. 2008;46(5):1461-1466.
119. Wahl MJ. Myths of dental surgery in patients receiving anticoagulant therapy.J Am Dent Assoc. 2000;131(1):77-81.
120. Jiménez Y, Poveda R, Gavaldá C, Margaix M, Sarrión G. An update on the management of anticoagulated patients for dental extractions and surgery.Med Oral Patol Oral Cir Bucal. 2008;13(3):E176-E179.
122. Hupp JR. Prevention and management of surgical complications. In: Hupp JR, Ellis E, Tucker MR (eds).Contemporary Oral and Maxillofacial Surgery. 5th ed. St. Louis, MO: Mosby Elsevier; 2008: 185-200.
123. ADA. Oral Anticoagulant and Antiplatelet Medications and Dental procedures. Available at https://www.ada.org/resources/research/science-and-research-institute/oral-health-topics/oral-anticoagulant-and-antiplatelet-medications-and-dental-procedures. Last accessed January 10, 2023.
124. Mingarro-de-León A, Chaveli-López B, Gavaldá-Esteve C. Dental management of patients receiving anticoagulant and/or antiplatelet treatment.J Clin Exp Dent. 2014;6(2):e155-e161.
125. 125. Al-Harkan AM, Al-Ayoub GA. Should antiplatelet and anticoagulant medications be discontinued before minor oral surgery procedures?J Can Dent Assoc. 2012;78:c24.
126. Little JW, Miller CS, Henry RG, McIntosh BA. Antithrombotic agents: implications in dentistry.Oral Surg Oral Med Oral Pathol Radiol Endod. 2002;93(5):544-551.
127. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.Circulation. 2007;115(6):813-818.
128. The American Academy or Oral medicine. Anticoagulant and Antiplatelet Medications and Dental Procedures. Available at https://www.aaom.com/index.php?option=com_content&view=article&id=80:antiplatelet-and-anticoagulant-agents-and-dental-procedures&catid=22:patient-condition-information&Itemid=120. Last accessed January 10, 2023.
129. Wynn RL, Meiller TF, Crossley HL.Drug Information Handbook for Dentistry. 23rd ed. Hudson, OH: LexiComp; 2017.
130. National Advisory Committee on Rural Health and Human Services. Improving Oral Health Care Services in Rural America. Available at https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/rural/2018-oral-health-policy-brief.pdf. Last accessed January 10, 2023.
131. 131. National Rural Health Association. Improving Rural Oral Healthcare Access. Available athttps://www.ruralhealthweb.org/NRHA/media/Emerge_NRHA/Advocacy/Policy%20documents/05-11-18-NRHA-Policy-Improving-Rural-Oral-Health-Access.pdf. Last accessed January 10, 2023.
132. Health Resources and Services Administration. What is Shortage Designation? Available at https://bhw.hrsa.gov/workforce-shortage-areas/shortage-designation. Last accessed January 10, 2023.
133. Health Resources and Services Administration. Health Workforce Shortage Areas. Available at https://data.hrsa.gov/topics/health-workforce/shortage-areas. Last accessed January 10, 2023.
134. Agency for Healthcare Research and Quality. National Healthcare Quality and Disparities Report. Available athttps://www.ahrq.gov/research/findings/nhqrdr/index.html. Last accessed January 10, 2023.
135. National Conference of State Legislatures. Improving Access to Care in Rural and Underserved Communities: State Workforce Strategies Health. Available athttp://www.ncsl.org/research/health/improving-access-to-care-in-rural-and-underserved-communities-state-workforce-strategies.aspx. Last accessed January 10, 2023.
136. Minnesota Department of Health. Emerging Health Professions. Available athttps://www.health.state.mn.us/facilities/ruralhealth/emerging/index.html. Last accessed January 10, 2023.
137. PEW Charitable Trusts. Expanding the Dental Team Increasing Access to Care in Public Settings. Available athttps://www.pewtrusts.org/en/research-and-analysis/reports/2014/06/30/expanding-the-dental-team. Last accessed January 10, 2023.
138. Garg S, Rubin T, Jasek J, Weinstein J, Helburn L, Kaye K. How willing are dentists to treat young children? A survey of dentists affiliated with Medicaid managed care in New York City, 2010.J Am Dent Assoc. 2013;144(4):416-425.
139. New York State Department of Health. Oral Health Plan for New York State. Available at https://www.health.ny.gov/prevention/dental/docs/oral_health_plan.pdf. Last accessed January 10, 2023.
140. PEW. Children's Dental Health Disparities. Available at https://www.pewtrusts.org/en/research-and-analysis/articles/2016/02/16/childrens-dental-health-disparities. Last accessed January 10, 2023.
141. Indian Health Service Data Brief April 2019. The Oral Health of American Indian and Alaska Native Children Aged 1–5 Years: Results of the 2018-19 IHS Oral Health Survey. Available at https://www.ihs.gov/doh/documents/surveillance/2018-19%20Data%20Brief%20of%201-5%20Year-Old%20AI-AN%20Preschool%20Children.pdf. Last accessed January 10, 2023.
142. Indian Health Service. The Public Health Nurse's Role in ECC Prevention and Early Intervention. Available athttps://www.ihs.gov/doh/documents/ecc/CommunityDocs/PHNRoleECCPreventionAndEarlyIntervention.pdf. Last accessed January 10, 2023.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.